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There exist in immunocompetent individuals two major groups of lymphocytes as 
defined by origin and function (see  1, 2).  One group, the non-thymus-processed (B) I 
lymphocytes, have in their lineage the capacity to synthesize humoral antibodies (3). 
"Ihymus-processed (T) lymphocytes, on the other hand, have never been found to pro- 
duce humoral antibodies to any significant degree  (4), but can be shown to function 
as helper cells for B cells when the latter are switched into antibody formation against 
several types of antigen (5). Both B and T lymphocytes can be shown to carry immu- 
nological specificity  (6, 7). Whether this is identical or not is still unknown. 
Controversy exists as to whether T and B lymphocytes can use the same generator 
of diversity for creating antigen-reactive cells. According to some investigators there 
are no detectable immunologlibulin  structures of classical  type on T cells (8), whereas 
others report IgM-like molecules on the outer membrane of T  lymphocytes (9-12). 
Making the assumption that B and T lymphocytes use the same genetic system for the 
creation of antigen-reactive cells, it would seem likely, in view of recent data support- 
ing the germ line theory for explaining antibody diversity (see 13), that the two groups 
of cells should show similar spectra of reactivity. In accordance with this, studies on 
cross-reacting albumins suggest that T and B lymphocytes would react with the same 
structures on the protein antigens (14, 15). On the other hand, using the small peptide 
hormone glucagon, results obtained showed a region of the molecule as a predominant 
T  cell activator and another site as the epitope against which most B cell products 
(=  humoral antibodies) were  directed  (16).  Specificity  differences  of  immune cells, 
responding either by DNA synthesis or by antibody production have been demon- 
strated also through the use of a cellular immunoadsorbent technique (17).  Dissimilar 
patterns of cross-reactivity of humoral antibodies and cellular immune responses have 
recently been observed by several groups (18-22). 
* This work was supported by the Deutsche Forschungsgemeinschaft,  the Swedish Cancer 
Society, Karolinska Instituter, and the Anders Otto Sw/irds Stiftelse. 
1  Abbreviations used in  this  paper: AFCP,  antibody-forming cell precursor; B cell, non- 
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CGG, chicken gamma globulin; HSA, human serum albumin; MBSA, MHSA, methylated 
BSA  and  HSA;  NIP,  4-hydroxy-3-iodo-5-nitrophenylacetic acid;  OA,  ovalbumin;  PVP, 
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We  have  approached  the  problem  of  recognition of  antigen by  B  vs.  T 
lymphocytes by using hapten-carrier systems, allowing the investigator to dis- 
tinguish between T  and B  cell activity against the same molecule (1,  23,  24). 
Bovine serum  albumin (BSA)  and  its  methylated  derivative  (MBSA)  were 
compared  for  their  ability to  induce BSA-specific antibody-forming cell pre- 
cursor (AFCP, B)  or helper (T)  activity. It has been shown that mice immu- 
nized with methylated albumins preferentially develop delayed hypersensitiv- 
ity,  whereas  the  native  albumins induce both  Arthus  reaction  and  delayed 
hypersensitivity (25). Our results demonstrate that while methylation of BSA 
drastically reduces the B  cell response against BSA, the T  cell response is un- 
affected as tested in quantitative assays. The experiments exclude that this is 
due to a changed likelihood per se of MBSA to make contact with B  lympho- 
cytes but would rather suggest different recognition systems for antigen on B 
and T  lymphocytes. 
Materials and Methods 
Antigens.--The  following immunogens were used: bovine serum  albumin ([BSA] Cohn 
fraction V) and chicken gamma globulin ([CGG] Cohn fraction II), both Koch-Light Labora- 
tories Ltd., Colnbrook, Buckinghamshire, England; human serum albumin ([HSA] 4  >(  crys- 
tallized; Nutritional  Biochemicals  Corporation, Cleveland, Ohio); and ovalbumin  ([OA] grade 
V; Sigma Chemical Company, St. Louis, Mo.). 
Methylated  BSA (MBSA) or HSA (MHSA) were prepared according to the method de- 
scribed by Fraenkel-Conrat and Olcott (26), which allows a practically complete esterification 
of the carboxyl groups in the absence of any other esteriflcation. 1 g of albumin, suspended in 
100 ml of absolute methanol, was incubated after the addition of 1 ml of concentrated hydro- 
chloric acid for 4 days at room temperature. It was then dialyzed against distilled water and 
equilibrated with  balanced salt  solution  (BSS). The preparations  were subsequently kept 
frozen at --20°C. 
Hapten-carrier  conjugates were synthesized using either  sulfanilic acid  (sulf) or  NIP 
(4-hydroxy-3-iodo-5-nitrophenylacetic  acid) as haptenic groups. Coupling reactions and de- 
terminations of the number of hapten groups bound per protein molecule were performed as 
described (24, 27, 28). The conjugates  used  were: sulfs-BSA, sulfs-OA, sulf12-CGG, sulfl..,- 
MBSA, sulfg-HSA, sulfs-MHSA,  NIPT-BSA, NIP3-OA, and NIPg-MBSA. 
MBSA and BSA have been compared in vitro with respect to their reactivity with anti- 
BSA antibodies. In passive hemagglutination inhibition studies the sulf conjugates of BSA 
and MBSA have been compared as inhibitors, since unconjugated MBSA interfered with the 
agglutination reaction at concentrations  >10  -7 M because of its positive charge. As can  be 
seen from Fig. 1, sulf-MBSA inhibited the BSA-specific agglutination only at much  higher 
concentrations than sulf-BSA (a factor of 300 at 50% inhibition). 
Animals,  Immunization,  and Cell Transfer.--Adoptive  secondary anti-sulf responses were 
investigated  in DBA/2  )<  C57BL/6  mice. High  responsiveness to  sulf seems genetically 
linked to H-2  a (H. Seiler, V. Schirrmacher, unpublished data). 2 CBA mice were used to stud), 
anti-NIP responses. Donor mice were primarily immunized with 100/zg of antigen emulsified 
in complete Freund's adjuvant (Difco Laboratories, Inc., Detroit,  Mich.) and administered 
subcutaneously into the footpads of the hind legs and in the flanks (total volume 0.2 ml). 
Rubin, B.  1972. The immune response against hapten-autologous protein conjugates in 
the mouse. I. Specificity of antibodies produced during the primary response against dinitro- 
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FIG.  1.  Inhibition of BSA-specific hemagglutination by BSA, sulf-BSA, sulf-MBSA,  and 
HSA. The anti-BSA antiserum was a  pool of sera from DBA/2  X  C57BL/6 animals immu- 
nized 4 wk before with 100/zg of BSA. 
Immune cell suspensions of donor mice were prepared from their spleens and lymph nodes 
(popliteal, inguinal, and axillary) by pressing them through a  stainless steel mesh. Single cell 
suspensions in BSS were prepared, washed, and counted for number and viability using trypan 
blue. Varying numbers of viable cells (indicated in each experiment) were transferred together 
with antigen intravenously into recipient mice of the same strain. These had previously been 
X-irradiated (29, 30) with 500 R  on the same day.  10 days later the mice were bled from the 
retroorbital plexus and the individual sera titrated for their antibody content. 
Serology and Statistical Analyses.--Anti-BSA and anti-sulf antibody titers were determined 
by passive hemagglutination using sheep erythrocytes coated with BSA by glutaraldehyde 2 
or directly coupled with sulf as described previously (31). All hemagglutinatlon titers reported 
here were resistant to reduction with 0.1  ~  2-mercaptoethanol. Anti-BSA titers could be in- 
hibited by  BSA at  about  10  "~ M (Fig.  1)  and  anti-sulf  titers by  sulfanyl-N-chloracetyl-L- 
tyrosine (32)  at about 10  -7 ~i. 
Binding capacities were determined for anti-NIP and anti-BSA anfisera in a modifed Farr 
ammonium sulfate precipitation assay by using  l~SI-labeled  NIP-e-aminocaproic acid  (amino- 
cap-N  t~sIP)  as hapten (27)  or BSA-1125 (30).  All binding data indicate micrograms of hapten 
or antigen bound per milliliter of serum. They were calculated from the serum dilution  at 
which 50% of the hapten/antigen in the incubation mixture (0.001  ~g/ml aminocap-N125Ip 
or 0.05 ~g/ml BSA-125I)  was bound. 
Serum antibody values were logarithmically transformed and means and standard  errors 
were calculated. In some experiments, determination of the "intragroup" variance was carried 
out using all data of a  given experiment. Use has been made of this variance to calculate the 
difference (d) that would be significant (P  =  0.05)  in a  Student's t test between two of the 
experimental groups in this experiment. 
Experimental  Design.--The aim  of the present study was to  compare the specificities of 
antigen-specific receptors on AFCP  (B) and helper (T) lymphocytes. According to the coop- 
hemoo 
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eration hypothesis (1, 5, 24), the induction of antibody synthesis against a thymus-dependent 
antigen requires an interaction of both AFCP and helper cells.  It is, therefore, important to 
establish a system where at least one of these cell types can be tested separately. The adoptive 
cell transfer system outlined in Fig. 2 was used for this purpose. This allows the helper cells 
to be tested independently by their capacity  to cooperate with hapten-specific AFCP  cells 
in a secondary anti-hapten response. 
Immune cells from donor  mice immunized against carrier A  (BSA)  or  A'  (MBSA)  are 
transferred together with hapten-specific cells from donor mice immunized against hapten- 
carrier B  (sulf-OA or NIP-OA)  into a  sublethally irradiated host. Stimulation with hapten- 
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FIG. 2.  Experimental design. 
carrier A (sulf-BSA or NIP-BSA) induces secondary anti-hapten and anti-carrier A responses. 
which can be measured 10 days after transfer. By subtracting the relevant control responses 
(stimulation in the absence of carrier A-specific  cells), we determine the helper activity (anti- 
hapten response) and the helper plus AFCP activity (anti-carrier A response) in the carrier 
A-specific  immune cell population. 
In the present study, this system was used to investigate in which way a chemical modifi- 
cation of BSA (methylation) affects its ability to interact with BSA-specific AFCP and helper 
cells. These studies include (a) comparison of BSA and MBSA immune cells in two coopera- 
tive cell transfer systems (anti-NIP and anti-sulf response), (b) transfer of decreasing amounts 
of BSA or MBSA immune cells in a cooperative cell transfer system, (c) test for the specificity 
of the helper cells in BSA and MBSA immune cells,  (d) comparison of the threshold dose for 
the induction of BSA-specific helper cells by BSA or MBSA, and (e) comparison of the thresh- 
old dose for the cooperative secondary anti-hapten response when hapten-BSA or hapten- 
MBSA are taken as secondary hapten-carrier conjugates. 1620  B  AND  T  CELL  RESPONSES  AGAINST ~ETHYLATED  BSA 
RESULTS 
Comparison  of BSA  and  MBSA  Immune  Cells  in  Cooperalive  Cell  Transfer 
Systems.--Table  I  shows the result of an experiment in which 2  X  10  v BSA or 
MBSA immune cells from donor animals immunized 4  wk before were  trans- 
ferred together  with  NIP-OA  immune  cells and  stimulated with  NIP-BSA. 
Good cooperative anti-NIP  responses were obtained  in  both  cases  (compare 
groups III and IV with II). However, when the secondary anti-BSA responses 
in groups III  and  IV  were compared,  a  clear-cut reduction in  case  of  trans- 
ferred MBSA immune cells (group IV) was observed (reduction factor  >  20). 
In  Table  II  BSA  and  MBSA  immune cells  are  compared in  a  cooperative 
TABLE  I 
Comparison ~[ BSA and MBSA Immune Calls. BSA-Specific Helper vs. BSA-Spec~gc 
Antibody Response in a Cooperative Cell  Transfer System  (Anti-NIP) 
Group 
No. 
I 
II 
III 
IV 
Immune cells 
transferred at day 0* 
NIP-OA 
"  -F BSA 
"  +  MBSA 
2  ° antigen 
io la,  g 
NIP-OA 
NIP-BSA 
Antigen-binding  capacity at day ll)~: 
Anti-NIP (logm) 
0.654  4-  0.110 
--0.600  4-  0.158 
0.239  4-  0.072 
0.333  4-  0.096 
Anti-BSA (loglo) 
<--1.000 
<--1.000 
0.731  4-  0.224 
--0.632  4-  0.126 
* 10  v NIP-OA immune ceils  (5 months); 2 3<  107 BSA or MBSA immune cells (4 wk). 
/zg aminocap-NmsIP or BSA-125I bound per milliliter  of serum; mean  4-  standard error 
of log 10 values; six animals per group. 
TABLE  II 
Comparison of BSA and MBSA Immune Cells. BSA-Specific Helper vs. BSA-Speclfic 
Antibody Response in  a Cooperative Cell  Transfer System  (Anti-sulf) 
Group No.  Immune  cells transferred  at day 0*  2  ° antigen 
Hemagglutination titer at day 10:~ 
Anti-sulf  Anti-BSA 
50 Ixg 
I  sulf-OA  sulf-OA  5.2  4-  0.40  0.0 
II  "  sulf-BSA  0.2  4-  0.15  0.0 
III  "  suIf-MBSA  1.9  4-  0.63  0.0 
IV  "  d- BSA  --  0.3  4-  0.50  3.6  =t=  1.22 
V  "  q-  "  sulf-BSA  3.3  4-  0.81  9.2  4-  1.20 
VI  "  +  "  sulf-MBSA  4.1  4-  0.38  5.5  -4-  0.92 
VII  "  q-MBSA  --  0.8  4-  1.10  0.8  4-  1.33 
VIII  "  -F  "  sulf-BSA  3.5  4-  0.51  4.0  -4-  1.37 
IX  "  q-  "  sulf-MBSA  4.6  4-  0.54  1.9  4-  0.80 
* 2 X  107 sulf-OA immune cells (5 wk); 1.5 X  107 BSA and MBSA immune cells (11 days). 
Logs passive hemagglufination titer; mean 4- one standard deviation; five animals per 
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secondary  anti-sulf response.  In  this  experiment  BSA  and  MBSA  have  been 
used  also  as secondary carriers for  the sulf hapten  (for reactivity of sulf-BSA 
and sulf-MBSA with anti-BSA antibodies see Fig.  1). The carrier specificity of 
the  adoptive  secondary  anti-sulf response  is  shown  in  the  first  three  groups. 
Very  similar  cooperative  anti-sulf  responses  were  obtained  when  BSA  or 
MBSA  immune cells were transferred  together with sulf-OA immune cells and 
stimulated  either  with  sulf-BSA  (groups  V  and  VIII)  or  sulf-MBSA  (groups 
VI  and IX).  Despite  this  similarity in helper  activity,  the AFCP  activity of 
the BSA  and MBSA immune cells seemed to be quite different. The anti-BSA 
titers in groups V  and VIII differ by about five log2 units. A  reduction of sec- 
ondary  anti-BSA titers can be seen also between groups V  and VI and between 
groups VIII and IX. 
In order to obtain more detailed information about helper and AFCP activity 
in BSA and MBSA immune cell suspensions, limiting dilution assays were car- 
ried  out in two further  experiments listed in Table III.  In experiment No.  1, 
5 and 1 million BSA immune cells were somewhat better as helpers than MBSA 
immune cells; in experiment No. 2, MBSA immune cells were better as helpers 
throughout  all  doses  tested.  Taking both  experiments together  there  appears 
to be no clear difference between BSA-specific helper activity in BSA and MBSA 
'FABLE III 
Comparison of BSA  and MBSA  Immune Cells.  Transfer of Decreasing Amounts of Cells 
in a  Cooperative Cell Transfer System 
Ex- 
peri- 
ment 
Group No.  Immune cells transferred at day 0*  2  ° antigen 
Hemagglutination titer 
at day 10~ 
Anti-sulf  Anti-BSA 
50 ug 
I  sulf-OA  sulf-BSA  1.5  0.0 
II, III  "  +  25BSA (MBSA)  "  8.0  (8.1)  7.1  (1.9) 
IV, V  "  +  5  "  (  "  )  "  6.6  (5.4)  2.5  (0.0) 
VI, VII  "  +  1  "  (  "  )  "  3.9  (2.6)  0.0  (0.0) 
VIII, IX  "  +  0.2  "  (  "  )  "  2.0  (2.1)  0.0  (0.0) 
I  sulf-OA  sulf-OA  6.4  0.0 
II  "  sulf-BSA  0.4  0.0 
III, IV  "  +  25BSA (MBSA)  "  3.8  (6.1)  11.3  (10.0) 
V, VI  "  +  5  "  (  "  )  "  2.5  (3.4)  8.5  (3.3) 
VII, VIII  "  -1-  1  "  (  "  )  "  0.7  (1.7)  4.7  (0.8) 
* Donor cells in experiment 1:4 X  l0  T sulf-OA immune cells (3 months); BSA and MBSA 
immune cells (amounts transferred indicated in millions)  (14 days). Donor cells in experiment 
2:2 X  107 sulf-OA immune cells (8 wk); BSA and MBSA immune cells (amounts transferred 
indicated in millions)  (4 wk). The responses obtained with MBSA immune cells are given in 
parentheses. 
2~ Log2 passive hemagglutination titer; mean values of five animals per group. Smallest 
significant difference (P =  0.05) for experiment 1: d  =  1.2, for experiment 2: d  =  1.5. 1622  B  AND  T  CELL  RESPONSES  AGAINST  METHYLATED  BSA 
immune cell suspensions.  On  the other hand,  a  pronounced reduction of anti- 
BSA  titers in case of  transferred  MBSA  immune  cells was  again observed in 
both experiments (compare groups II and III in experiment 1 and V  and VI in 
experiment 2). 
The  experiments  reported  so  far  do  not  answer  the  question  of  whether 
MBSA induces specific helper cells or exerts its activation of helper function in 
a nonspecific way, e.g., due to its positive charge it might perhaps induce cells 
to  produce  a  factor  substituting  for  carrier-specific helper  cells.  The  helper 
specificity of BSA and MBSA immune cells was investigated (Table IV). The 
anti-sulf responses in groups VI-IX  demonstrate that  MBSA as well as BSA 
immune cells have  a  helper activity specific for BSA but not HSA (for cross- 
reactivity between  BSA and HSA see Fig.  1). When MBSA and  MHSA were 
taken  as secondary carriers (groups X-XIII)  a  cooperative anti-sulf response 
was obtained only with the former. Apart from confirming the BSA specificity 
of  the helper cells,  these results indicate  that  the  methylation procedure has 
not introduced into the albumin molecules new determinants which cross-react 
on  the helper level. On  the antibody level no  new  determinants could be de- 
tected either (25). 
Threshoht  Dose for  the  Aclivalion  of  BSA-Specific  Helper  Cells  by  BSA  or 
MBSA.--The  comparison  of  BSA  and  MBSA  immune  cells  showed  that 
MBSA  had  a  reduced ability to react with  BSA-specific AFCP cells, whereas 
there  was  no  reduction  of  its  ability to  react  with  BSA-specific helper cells. 
One could argue  that in  the experiments reported the antigen doses were  too 
high  to  allow  a  detection  of  a  difference between  the reactivity of BSA  and 
MBSA  at the helper level. Therefore the threshold doses for the activation of 
TABLE  IV 
Comparison of BSA and MBSA Immune Cells. Specificity  of the Helper Cells. 
Group No.  immune cells transferred at day 0*  2  ° antigen 
Hemagglutination titer at day 10~ 
Anti-sulf  Anti-BSA 
20 #g 
I  sulf-CGG  sulf-CGG  5.4  0.0 
II  "  sulf-BSA  1.4  0.0 
III  "  sulf-HSA  1.2  0.0 
IV  "  sulf-.'ViB  SA  1.8  0.0 
V  "  sulf-MHSA  1.9  0.0 
VI, VII  "  +  BSA (MBSA)  sulf-BSA  4.5  (3.5)  9.3  (3.7) 
VIII, IX  "  -b  "  (  "  )  sulf-HSA  1.4  (1.3)  3.5  (0.0) 
X, XI  "  -k  "  (  "  )  sulf-MBSA  3.7  (3.7)  5.5  (0.5) 
XII, XIII  "  q-  "  (  "  )  sulf-MHSA  1.6  (1.9)  1.7  (0.t) 
* 1.5  X  107 sulf-CGG  immune  cells (4 months); 2 X  107 BSA or MBSA immune  cells 
(17 days). The responses obtained with MBSA immune cells are given in parentheses. 
:~ Log2 passive hemagglutination titer; mean of five animals per group. Smallest significant 
difference (P =  0.05) d =  1.3. VOLKER  SCItlRR!VIACI-IER AND  HANS  WIGZELL  1623 
BSA-specific helper  cells by  BSA  or  MBSA  were determined:  (a)  for primary 
induction  of helper  cells  (Table  V)  and  (b)  for reactivity  with  the helper  cells 
in  a  cooperative  secondary  anti-hapten  response  (Table  VI). 
Table  V  shows the results of an  experiment  where BSA  and  MBSA  immune 
cells  from  animals  immunized  with  different  antigen  doses  (100-0.1  #g)  were 
transferred  together  with  sulf-OA  immune  cells  and  tested  for  their  helper 
TABLE  V 
Threshold  Dose for the Acitvation  of BSA-Specific  Helper Cells  by BSA  or MBSA. 
Primary Induction  of Helper Cells 
Group No.  Immune cells transferred at day 0*  2  ° antigen 
Hemagglutination titer 
at day 10+  + 
Anti-sulf  Anti-BSA 
5o tzg 
I  sulf-OA  sulf-OA  8.4  0.0 
II  "  sulf-BSA  1.9  0.0 
III, IV  "  +  BSA (MBSA) 1  ° 100  "  8.0  (6.2)  5.8  (0.6) 
V, VI  "  +  "  (  "  )  1  °10  "  8.9  (7.3)  5.2  (0.8) 
VII, VIII  "  +  "  (  "  )  1  ° 1  "  5.5  (4.3)  0.9  (0.0) 
IX, X  "  +  "  (  "  )1°0.1  "  2.5  (2.0)  0.0  (0.0) 
XI  "  -b normal cells (FC)  "  1.8  0.0 
* 3  X  107 sulf-OA immune cells (2  months); 2  X  107 BSA or MBSA immune cells from 
animals immunized 2 wk before with the indicated amount (/zg)  of antigen in Freund's com- 
plete adjuvant  (FC).  Control  (XI):  cells from  animals  immunized  2  wk  before with  FC 
alone. The responses obtained with MBSA immune cells are given in parentheses. 
:~ Log2 passive hemagglutination titer; mean of five animals per group. Smallest significant 
difference (P  =  0.05) d  =  1.2. 
TABLE  VI 
Threshold  Dose for the Activation  of BSA-Specific  Helper Cells  by BSA  or MBSA. 
Induction  of a Secondary Anti-NIP Response with BSA-Specific  Helper 
Cells  and NIP-BSA  or NIP-MBSA  as Antigen 
Group No.  Immune cells transferred  Anti-NIP at day  at day 0*  2  ° antigen  Dose  10t (log10) 
/lg 
I  NIP-OA  NIP-OA  10  0.348  -4-  0.189 
II  "  NIP-BSA  10  0.039  ±  0.057 
III  "  NIP-MBSA  10  0.042  -4-  0.061 
IV  "  +  BSA  NIP-BSA  1  0.012  ±  0.103 
V  "  +  "  "  10  0.427  4-  0.126 
VI  "  +  "  NIP-MBSA  1  0.013  4-  0.073 
VII  "  +  "  "  10  0.306  4-  0.086 
* 1.6  X  107 NIP-OA immune cells (3 months); 2  X  107 BSA immune cells (6 wk). 
:~ #g  aminocap-N125Ip  bound  per  milliliter of serum;  mean  4-  standard  error  of  logt0 
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activity in a secondary anti-sulf response.  Cells from animals immunized with 
complete Freund's  adjuvant  alone  (group XI)  and  from animals  immunized 
with 0.1 #g of BSA or MBSA (groups IX and X) contained no helper activity. 
By increasing  the  antigen  dose,  a  helper  activity was  demonstrated  in  both 
cases (BSA and MBSA)  at a dose of 1 #g per animal (groups VII and VIII). 
This indicates  that  there is no significant  difference in  the threshold  dose for 
the induction  of BSA-specific helper cells by BSA or MBSA. 
The threshold dose of BSA and MBSA as secondary carriers in a cooperative 
secondary anti-NIP response with BSA-specific helper cells was determined in 
the experiment shown in Table VI. NIP-BSA and NIP-MBSA did not induce 
a cooperative anti-NIP response at a dose of 1/~g (groups IV and VI) but did 
so at  10 #g (groups V  and VII). The latter responses were as high  as the ho- 
mologous response  (group  I).  This  demonstrates  that  the  ability  of  BSA  to 
react with  BSA-specific helper cells was not affected by the methylation pro- 
cedure. This finding was confirmed in the secondary anti-sulf response. Sulf-OA 
immune cells were transferred  alone or together with  BSA  immune cells into 
recipient mice which were stinmlated with different amounts of either sulf-BSA 
or sulf-MBSA. As shown in Fig. 3 the dose-response curves were rather similar, 
the one obtained with sulf-MBSA being shifted to lower antigen concentrations. 
The latter observation could be explained by a higher intrinsic immunogenicity 
of sulf-MBSA compared with sulf-BSA, since it induced  a higher  anti-sulf re- 
sponse also in the absence of BSA-specific helper cells (compare the heterologous 
responses in Fig. 3). Thus, in none of the systems tested (lid BSA-specific helper 
cells react less well with MBSA  than with BSA. 
DISCUSSION 
In the present article we have presented  evidence that methylation of BSA 
to more than 95 % reduces its ability to react with anti-BSA antibodies (Fig. 1) 
and with BSA-specific AFCP (B) cells. However, its reactivity with BSA-specific 
helper (T) cells remains unchanged,  as demonstrated by an identical threshold 
concentration of BSA and MBSA for activation of helper cells.  The differential 
effect of methylation could be shown on two levels: (a) for the primary induc- 
tion  of BSA-specific AFCP  or helper cells  by BSA  and  MBSA,  respectively, 
and  (b)  for  the  secondary  interaction  of  BSA-specific AFCP  or  helper  cells 
with hapten-BSA and hapten-MBSA conjugates. 
The two main entities  upon  which valid interpretation  of our data  depend 
are the types of immune cells involved in  the cooperative cell transfer system 
studied  and  the  impact  of  the  methylation  of  BSA  on  its  physicochemical 
properties, which could affect its recognition by AFCP and helper cells. 
The experimental evidence identifying helper cells as T  and AFCP as B cells 
may be summarized as follows:  (a)  Educated  thymus cells substitute  for car- 
rier-specific helper cells (1, 33), whereas anti-carrier antibody does not, at least 
in  conventional  hapten-carrier  systems  (1, 24).  (b)  Anti-0  treatment  in  the 
presence of complement inhibits the function of carrier-specific helpers but not VOLKER  SCHIRRMACHER  AND  IiANS  WIGZELL  1625 
of hapten-specific AFCP cells  (34).  (c)  Helper cells are not retained on anti- 
immunoglobulin-coated  columns, which do retain AFCP lymphocytes (35, 36). 
(d)  Lymphocytes potentially capable of producing measurable humoral anti- 
body belong to the B  type only (4). 
With these properties of helper (T) and AFCP (B) cells in mind we may ex- 
anti- su/f  hemagglutination 
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FIG. 3.  Comparison of cooperative anti-sulf responses obtained with  sulf-BSA and suIf- 
MBSA in an adoptive cell transfer system. 500 R irradiated mice were injected with 3 X  107 
sulf-OA immune cells (8 wk) alone (open symbols) or together with 1.5 X  107 BSA immune 
cells (8 wk, closed symbols). They were stimulated with  the indicated amounts of sulf-OA 
([]), sulf-BSA (e, (3), or sulf-MBSA (A, ~). Symbols and vertical bars represent geometric 
means and standard  deviations of anti-sulf hemagglutination titers  (log2) obtained  10 days 
after cell transfer (six animals per group). Anti-sulf titers were titrated in phosphate-buffered 
saline containing 0.45% PVP K  60  (Alex Engblom, Borers, Sweden), which increased the 
sensitivity of the assay by three log~ titers  (V. Schirrmacher, unpublished data). 1626  B  AND  T  CELL  RESPONSES  AGAINST  METHYLATED  BSA 
amine the impact of the methylation of BSA on its physicochemical properties 
which  could influence cellular recognition.  Since  the methylation reaction in- 
volves only the negatively charged carboxyl groups of the molecule (26),  the 
most pronounced effect of the chemical modification is an alteration of charge. 
In agarose electrophoresis at pH 7.2 BSA moves to the positive, MBSA to the 
negative electrode, whereas sulf-MBSA is neutraI? One could therefore try to 
attribute the differential reactivity of BSA-specific AFCP and helper cells with 
MBSA to its altered charge. There are two arguments against this assumption: 
(a) the differential reactivity of BSA-specific B  and T  cells with MBSA is also 
observed when  MBSA  is  presented  as  a  neutral  sulf-MBSA  conjugate,  and 
(b) chemical modifications at the positively charged amino groups of BSA (e.g. 
acetylation) had a similar effect as the methylation. ~ 
An alternative explanation for the poor humoral anti-BSA response induced 
by MBSA would be that MBSA as a consequence of a change in physicochemi- 
cal properties is less likely in vivo to interact with any kind of B lymphocytes 
than native BSA. Arguments against this interpretation come from the results 
obtained when having the hapten  on  BSA  or MBSA  as secondary carriers in 
cooperative cell  transfer systems using graded doses of antigen  for secondary 
stimulation.  Here,  the  anti-hapten  response would  require  the hapten-carrier 
complex to come in close physical contact with  the B  lymphocyte immune to 
the hapten determinant. The results demonstrate no difference between hapten- 
BSA and hapten-MBSA conjugates in such tests, thus excluding the possibility 
that  MBSA  is  in  itself  different  from BSA  with  regard  to  making  physical 
contact to B lymphocytes. 
Having so far argued against unspecific factors which could have influenced 
our results,  we must consider  the possibility that B  and  T  lymphocytes may 
have different or largely nonoverlapping spectra of inducing antigenic specifici- 
ties.  Glucagon has been shown  to carry on its carboxyl end  a T  cell-inducing 
site  whereas  humoral  antibody  is  directed  primarily  against  epitopes  at  the 
amino-terminal piece (16). Recent data from other groups (21,  19) support our 
observations with  methylated BSA,  in so far as  they also demonstrate a  dif- 
ferential effect of chemically modified proteins (i.e. acetoacetylated flagellin and 
reduced S-carboxymethylated lysozyme) on their ability to induce humoral and 
cell-mediated immune responses.  It is  tempting  to speculate on the fact that 
all these modifications exert their effect in the same direction, namely suppres- 
sion on the AFCP level. This seems to hold true also for complex cellular anti- 
gens such  as sheep red  blood  cells  (22),  an  observation which  hopefully will 
have practical  implications, e.g.,  in  tumor therapy. In some systems the sup- 
pressive  effect  on  the  antibody  level  is  accompanied  by  an  even  enhanced 
ability of the modified antigen to induce cell-mediated imnmnity (21, 22). These 
data in combination with our results would suggest that T  cells can recognize 
Schirrmacher,  V.,  and  H.  Wigzell.  Immune  responses against  native  and  chemically 
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other structures on  a  macromolecule than  can B  ceils  (with some structures 
recognized by both), whereas work on cross-reacting albumins has yielded re- 
sults  suggesting  similarity  if  not  identity  between  T  and  B  cell  receptor 
specificities (14,  15). 
At  this point it should be realized that  recognition with  regard to T  or B 
cell activation by antigen involves at least two steps, actual specific combina- 
tion between antigen-binding receptors on the cell surface with antigen plus a 
relatively nonspecific activation process characteristic for the cell type involved 
(37). That such a latter switch-on process might be highly typical for one of the 
two groups of lymphocytes is shown by studies on mitogens, where the mitogen 
can be shown to be bound equally well (e.g. phytohemagglutinin or concanavalin 
A [38]) to both B and T  lymphocytes. Yet, in the soluble form of the mitogen, 
only T  cell activation will take place, whereas if the same mitogen is rendered 
insoluble primarily B cell activation will be seen (39). Thus, analogies between 
binding of antigen to lymphocytes as a direct measure of activation might be 
very misleading. 
However, some interpretations of the present results are possible with regard 
to antigen-binding receptors on B  vs. T  cells.  MBSA will  combine 300 times 
less well than BSA with anti-BSA antibodies (Fig. 1), suggesting that 0.3 % of 
native determinants are left on MBSA. Humoral antibodies can be considered 
as good analogues of soluble antigen-binding receptors for at least B  lympho- 
cytes (40)  and humoral antibodies should have, if anything, a better access to 
antigenic sites than would cell-bound receptors for antigen. The finding that, 
despite this, MBSA is equal to BSA with regard to inducing anti-BSA helper 
activity when using graded doses of antigen in primary or secondary immune 
systems, we consider incompatible with the idea that BSA-specific B and T cells 
react with the very same determinants. 
Differences in specificities of B and T  cells,  as they are now apparent in sev- 
eral systems (16-22, 41-44), could mean either (a) that the recognition systems 
for antigen on B  and T  cells are principally different or (b)  that  they are of 
identical nature,  only differing in the spectra of their specificities. The latter 
could have been affected by genetically determined unresponsiveness (the defect 
appears to localize preferentially either in AFCP or helper cells [see 45]) and/or 
by different selection mechanisms operating during ontogeny in the diversifica- 
tion of B  and T  cell specificity (46, 47). We would favor conception a since it 
allows the assumption that T  cells recognize larger areas on a protein molecule 
than do B  cells.  This would be a  reasonable way of explaining why chemical 
modifications of antigens  preferentially suppress humoral  antibody induction 
against it. 
SUMMARY 
Immune cells induced by bovine serum albumin  (BSA)  and its methylated 
derivative (MBSA) have been compared in a cooperative cell transfer system 1628  /3  AND  T  CELL  RESPONSES  AGAINST  METHYLATED  /3SA 
for their content  of BSA-specific antibody-forming cell precursors  (AFCP,  B) 
and BSA-specific helper  (T)  cells. When MBSA immune cells were transferred 
together  with  hapten-primed  cells  into  recipient  mice  which  were  stimulated 
by a hapten-BSA conjugate,  their cooperative secondary anti-hapten  response 
was as good as in case of transferred  BSA immune cells. Their secondary anti- 
BSA response, however, was markedly reduced (reduction factor >  30). Hapten- 
MBSA conjugates had the same capacity to react with BSA-specific helper cells 
in  the cooperative secondary anti-hapten  response  as hapten-BSA  conjugates 
but had a reduced ability to react with BSA-specific AFCP cells. In spite of the 
pronounced  reduction  of the  B  cell  response,  MBSA had  the  same  threshold 
dose as BSA for activating BSA-specific T  cells. 
These  data  suggest  that  B  and  T  cells  recognize different  epitopes  on  the 
BSA molecule, only those recognized by B cells being affected by the methyla- 
tion procedure. 
We are grateful to Doctors B. Rubin,  P.  Golstein, E. Lamon, and  R.  Gatti for valuable 
criticism and for reading the manuscript. 
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